Literature DB >> 26786867

Characterization and Comparison of Patient Subgroups Suspicious for IgG4-Related Disease and Malignant Lymphoma in Patients Followed-up for Sjögren's Syndrome.

Antónia Szántó1, Katalin Szabó2, Gábor Nagy3, Csaba Molnár4, Margit Zeher5.   

Abstract

Differential diagnosis of patients with Sjögren's syndrome (SS), IgG4-related disease (IgG4-RD) and SS patients having high risk for lymphoma (LHR) can be challenging. Some patients with IgG4-RD might be misdiagnosed as having SS. There are special symptoms of SS that raise the possibility of IgG4-RD whereas other symptoms identify patients as having LHR. The purpose of this study was to characterize and compare patients with SS, possible IgG4-RD and SS patients with LHR. Sixty-five SS patients were divided into 4 subgroups according to having possible IgG4-RD (n = 15), LHR (n = 16), eligible for both aforementioned groups (n = 20) and not eligible for either group (n = 14), respectively. Four patients fulfilled the diagnostic criteria for IgG4-RD. The serum levels of IgG4 were significantly higher in patients suspicious for IgG4-RD compared to that of LHR patients (0.46 g/l vs. 0.12 g/l, p = 0.032). Shared features of the patient groups (salivary gland swelling (SGS) and lymphadenopathy), were separately analysed: SGS patients had higher IgG4/IgG ratio (p = 0.036), lymphadenopathic patients had higher IgG4 levels (p = 0.042). Some patients may be "hidden" under the diagnosis of SS. Although patients with LHR and patients with possible IgG4-RD share some symptoms, they differ significantly regarding IgG4 levels and IgG4/IgG ratio.

Entities:  

Keywords:  IgG4-related disease; Malignant lymphoma; Sjögren’s syndrome

Mesh:

Substances:

Year:  2016        PMID: 26786867     DOI: 10.1007/s12253-016-0041-1

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  17 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

2.  Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations.

Authors:  John H Stone; Arezou Khosroshahi; Vikram Deshpande; John K C Chan; J Godfrey Heathcote; Rob Aalberse; Atsushi Azumi; Donald B Bloch; William R Brugge; Mollie N Carruthers; Wah Cheuk; Lynn Cornell; Carlos Fernandez-Del Castillo; Judith A Ferry; David Forcione; Günter Klöppel; Daniel L Hamilos; Terumi Kamisawa; Satomi Kasashima; Shigeyuki Kawa; Mitsuhiro Kawano; Yasufumi Masaki; Kenji Notohara; Kazuichi Okazaki; Ji Kon Ryu; Takako Saeki; Dushyant Sahani; Yasuharu Sato; Thomas Smyrk; James R Stone; Masayuki Takahira; Hisanori Umehara; George Webster; Motohisa Yamamoto; Eunhee Yi; Tadashi Yoshino; Giuseppe Zamboni; Yoh Zen; Suresh Chari
Journal:  Arthritis Rheum       Date:  2012-10

3.  EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome.

Authors:  Raphaèle Seror; Philippe Ravaud; Simon J Bowman; Gabriel Baron; Athanasios Tzioufas; Elke Theander; Jacques-Eric Gottenberg; Hendrika Bootsma; Xavier Mariette; Claudio Vitali
Journal:  Ann Rheum Dis       Date:  2009-06-28       Impact factor: 19.103

4.  Chronic sclerosing sialadenitis as one of the immunoglobulin G4-related diseases: a clinicopathological study of six cases from Central Europe.

Authors:  Jan Laco; Ales Ryska; Petr Celakovsky; Helena Dolezalova; Radovan Mottl; Lubos Tucek
Journal:  Histopathology       Date:  2011-03-25       Impact factor: 5.087

5.  Necessity of early intervention for IgG4-related disease--delayed treatment induces fibrosis progression.

Authors:  Yui Shimizu; Motohisa Yamamoto; Yasuyoshi Naishiro; Gohta Sudoh; Keisuke Ishigami; Hidetaka Yajima; Tetsuya Tabeya; Mikiko Matsui; Chisako Suzuki; Hiroki Takahashi; Nobuhiko Seki; Tetsuo Himi; Ken Yamashita; Hiroko Noguchi; Tadashi Hasegawa; Yasuo Suzuki; Saho Honda; Takashi Abe; Kohzoh Imai; Yasuhisa Shinomura
Journal:  Rheumatology (Oxford)       Date:  2012-12-19       Impact factor: 7.580

6.  Clinical characteristics of Mikulicz's disease as an IgG4-related disease.

Authors:  Masafumi Moriyama; Akihiko Tanaka; Takashi Maehara; Yukiko Ohyama; Mayumi Shimizu; Hitoshi Nakashima; Jun-Nosuke Hayashida; Shoichi Shinozaki; Yoshiaki Kubo; Sachiko Furukawa; Toshihiro Kikuta; Seiji Nakamura
Journal:  Clin Oral Investig       Date:  2012-12-16       Impact factor: 3.573

Review 7.  IgG4-associated sialadenitis.

Authors:  Julia T Geyer; Vikram Deshpande
Journal:  Curr Opin Rheumatol       Date:  2011-01       Impact factor: 5.006

Review 8.  Recent concepts of autoimmune pancreatitis and IgG4-related disease.

Authors:  Kazuichi Okazaki; Kazushige Uchida; Hideaki Miyoshi; Tsukasa Ikeura; Makoto Takaoka; Akiyoshi Nishio
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

Review 9.  Lymphadenopathy of IgG4-related sclerosing disease: three case reports and review of literature.

Authors:  Ikuo Shimizu; Kentaro Nasu; Keijiro Sato; Hiromitsu Ueki; Daigo Akahane; Masahiko Sumi; Mayumi Ueno; Naoaki Ichikawa; Naoko Asano; Masaru Kojima; Hikaru Kobayashi
Journal:  Int J Hematol       Date:  2010-12-01       Impact factor: 2.490

10.  Description of patients with IgG4-related disease from a Hungarian centre.

Authors:  A Szántó; G Nagy; C S Molnár; Z Griger; T Tarr; M Zeher
Journal:  Scand J Rheumatol       Date:  2014-02-07       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.